Huddinge, Sweden

Patric Fransson

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patric Fransson. Retrieved from https://idiyas.com/inventor/patric-fransson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patric Fransson: Innovator in Selective Hydrogenation

Introduction

Patric Fransson is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of chemistry, particularly in the area of selective hydrogenation. His work has implications for various industrial applications, showcasing the importance of innovation in chemical processes.

Latest Patents

Fransson holds a patent for the selective hydrogenation of a C3-C5 alkyl alcohol. This patent involves the production of lower alkanesulphonate salts of cyanobenzylamines through a selective recrystallization process. The salts can be produced advantageously following the selective hydrogenation of a dicyanobenzene to a cyanobenzylamine in the presence of a C,alkyl alcohol. This innovation highlights the potential for improved chemical synthesis methods.

Career Highlights

Patric Fransson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to advancements in pharmaceutical chemistry. With a focus on innovative solutions, he continues to push the boundaries of what is possible in his field.

Collaborations

Fransson has collaborated with Magnus Sjögren, further enhancing the impact of his research and innovations. Their partnership exemplifies the collaborative spirit that drives progress in scientific research.

Conclusion

Patric Fransson's contributions to the field of selective hydrogenation demonstrate the vital role of inventors in advancing chemical processes. His patent and work at AstraZeneca reflect a commitment to innovation that benefits the industry and society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…